LGBT Cancer Project

Therapeutic Areas: Oncology | Dermatology | Family Medicine

Malignant Melanoma Clinical Trials

A listing of Malignant Melanoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Research Center
Birmingham Alabama

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination with Nivolumab in Select Advanced Cancers

Arizona

Gilbert Arizona 85234

A Phase 1/Phase 2 clinical study for patients using Rovalpituzumab tesirine

Phoenix Arizona 85054

A Phase 1/Phase 2 clinical study for patients using Rovalpituzumab tesirine

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Tucson Arizona 85719

A clinical research study of CPI-444 and CPI-444 + atezolizumab

California

Research Center
Los Angeles California

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination with Nivolumab in Select Advanced Cancers

Research Center
Los Angeles California

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

Research Center
Sacramento California

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

Research Center
San Diego California

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

Research Center
San Francisco California

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination with Nivolumab in Select Advanced Cancers

Duarte California 91010

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

Duarte California 91010

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating NEO-PV-01, Nivolumab and Adjuvant

Duarte California 91010

Patients are needed to participate in a clinical research study of CMP-001 and Pembrolizumab to evaluate Stage IV Skin Melanoma

La Jolla California 92037-0845

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

La Jolla California 92037-0845

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

Los Angeles California 90095

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Los Angeles California 90095

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

Los Angeles California 90095

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

Los Angeles California 90095

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

Los Angeles California 90095

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating IMCgp100, durvalumab and tremelimumab for the treatment of Malignant Melanoma, Cutaneous Melanoma

Los Angeles California 90025

Patients are needed to participate in a clinical research study evaluating IMCgp100, durvalumab and tremelimumab for the treatment of Malignant Melanoma, Cutaneous Melanoma

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating NEO-PV-01, Nivolumab and Adjuvant

Los Angeles California 90095

Patients are needed to participate in a clinical research study of CMP-001 and Pembrolizumab to evaluate Stage IV Skin Melanoma

San Diego California 92103

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

San Francisco California 94143

A clinical research study of CPI-444 and CPI-444 + atezolizumab

San Francisco California 94115

A Phase 1/Phase 2 clinical study for patients using Rovalpituzumab tesirine

Santa Monica California 90404

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

Stanford California 94305

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Colorado

Research Center
Aurora Colorado

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination with Nivolumab in Select Advanced Cancers

Research Center
Aurora Colorado

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

Research Center
Denver Colorado

A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors

Aurora Colorado 80045

A clinical research study of CMP-001 and Pembrolizumab for the treatment of Malignant Melanoma

Aurora Colorado 80045

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Aurora Colorado 80045

A Phase 1/Phase 2 clinical study for patients using Rovalpituzumab tesirine

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of CMP-001 and Pembrolizumab to evaluate Stage IV Skin Melanoma

Denver Colorado 80218

A Phase 1/Phase 2 clinical study for patients using Rovalpituzumab tesirine

Connecticut

Research Center
Farmington Connecticut

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

Research Center
New Haven Connecticut

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

New Haven Connecticut 06510

A clinical research study of CPI-444 and CPI-444 + atezolizumab

District of Columbia

Washington District of Columbia 20057

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Washington District of Columbia 20007

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

Washington District of Columbia 20007

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

Florida

Research Center
Miami Florida

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

Research Center
Miami Florida

A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors

Research Center
Port St. Lucie Florida

A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors

Research Center
Sarasota Florida

A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors

Research Center
Tampa Florida

A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors

Gainesville Florida 32608

A Phase 1/Phase 2 clinical study for patients using Rovalpituzumab tesirine